Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Johnson & Johnson HIV combination succeeds in mid-stage study
Johnson & Johnson HIV combination succeeds in mid-stage study
Johnson & Johnson HIV combination succeeds in mid-stage study
Submitted by
admin
on November 3, 2015 - 9:20am
Source:
Yahoo/Reuters
News Tags:
JNJ
HIV
cabotegravir
rilpivirine
ViiV Healthcare
Headline:
Johnson & Johnson HIV combination succeeds in mid-stage study
Do Not Allow Advertisers to Use My Personal information
